---
title: "Nanopore Sequencing Applications in Virus Research"
created: "2026-06-08"
updated: "2026-06-08"
type: concept
tags: [nanopore, virology, review, genome-assembly, transcriptomics, epigenetics, direct-RNA-sequencing]
sources:
  - type: paper
    url: "https://doi.org/10.3390/v16050798"
    title: "The Applications of Nanopore Sequencing Technology in Animal and Human Virus Research"
    authors: "Ji CM, Feng XY, Huang YW, Chen RA"
    journal: "Viruses"
    date: "2024-05-16"
confidence: high
---

# Nanopore Sequencing Applications in Virus Research

## Overview

Comprehensive review covering the breadth of nanopore sequencing applications across animal and human virology, published by researchers at South China Agricultural University and Zhejiang University [1]. Covers viral detection/surveillance, genome assembly, novel virus discovery, transcriptome analysis, and epigenetic modification detection — representing one of the most thorough reviews of ONT in virology to date [1].

## Key Application Areas

### 1. Viral Detection and Surveillance
- **Ebola (EBOV)**: Real-time sequencing of 142 Guinean patient samples during 2015 outbreak using MinION — identified GN1 and SL3 transmission lineages between Guinea and Sierra Leone [1]
- **SARS-CoV-2**: 29 complete genomes from Hangzhou clinical specimens in 8-hour workflow (Jan–Mar 2020); enabled hospital transmission tracking [1]
- **African Swine Fever Virus (ASFV)**: Rapid detection with ~100% mortality rate pathogen — nanopore enables field-deployable surveillance [1]
- **Influenza A**: Real-time monitoring of seasonal and pandemic strains [1]

### 2. Novel Virus Discovery
- SARS-CoV-2 initial genome determination from clinical specimens [1]
- Within-specimen variant tracking (SNVs at 40–80% frequency detectable; <40% challenging) [1]
- Structural variation detection: 16 candidate deletions (15–1840 bp) identified across SARS-CoV-2 genes [1]

### 3. Transcriptome Assembly and Novel Transcript Discovery
| Virus | Key Finding | Method |
|-------|-------------|--------|
| Hepatitis D (HDV) | Full-length genomes in single fragment; new subtype s22 from Cameroon | VIRiONT pipeline + nanopore [1] |
| Varicella Zoster (VZV) | 114 novel transcripts, 10 spliced variants, 25 TSS/TES isoforms, ncroRNAs class | MinION cDNA sequencing [1] |
| Pseudorabies (PRV) | 19 novel protein-coding genes, 3 complex transcripts, 121 transcriptional overlaps | Nanopore + PacBio + Illumina tri-platform [1] |
| Adenovirus type 2 | ~900 alternatively spliced mRNAs (800 new), 14 novel transcripts | Direct RNA sequencing [1] |
| SARS-CoV-2 sgRNA | 14 canonical + 7 non-canonical subgenomic RNAs; bidirectional template switches | NRCeq nanopore recappable sequencing [1] |

### 4. Chemical Modification Detection (Epitranscriptomics)
Nanopore's unique capability for **direct RNA/DNA sequencing** enables detection of modifications without chemical treatment [1]:

| Virus | Modification | Finding |
|-------|-------------|---------|
| HSV-1 | m6A | ICP27 protein suppresses m6A; depletion affects early gene expression [1] |
| Adenovirus | m6A (DRACH motif) | Not essential for early infection but regulates late transcript splicing [1] |
| HCoV-229E | m5C | Sequence-specific methylation patterns across transcripts [1] |
| SARS-CoV-2 | 41+ RNA modifications | Most frequent motif: AAGAA; modified RNAs have shorter poly(A) tails [1] |
| β-coronaviruses | m6A | Replication controlled by METTL3, YTHDF1/3 host factors — therapeutic target potential [1] |
| PRRSV | m5C | Preferential enrichment around translational start codons of sgmRNAs [1] |

## Critical Analysis

### Strengths ✅
✅ **Comprehensive scope** — covers detection through epigenetics across animal/human viruses [1]  
✅ **Direct RNA sequencing emphasis** — unique ONT capability highlighted throughout [1]  
✅ **Practical examples** — real outbreak applications (Ebola, SARS-CoV-2) [1]  
✅ **Therapeutic implications** — m6A modification as potential antiviral target [1]  

### Limitations ⚠️
⚠️ **Review format** — synthesizes existing literature rather than presenting new data [1]  
⚠️ **Limited quantitative comparison** to Illumina/PacBio for most applications [1]  
⚠️ **Focus on proof-of-concept studies** — few large-scale clinical validations cited [1]  
⚠️ **Error rate discussion minimal** — doesn't address when nanopore errors could mislead interpretation [1]  

### Unanswered Questions ❓
❓ Cost-effectiveness vs Illumina for routine surveillance?  
❓ Standardization of epigenetic modification calling across labs?  
❓ Integration with AI/ML for automated variant detection?  

## Cross-References

- [Nanopore Sequencing Minion](nanopore-sequencing-minion.md) — MinION platform overview and field deployment
- [Clinical Metagenomics Viral Detection](clinical-metagenomics-viral-detection.md) — clinical metagenomics context
- [Next Generation Sequencing](next-generation-sequencing.md) — sequencing technology comparison
- [Pandemic Influenza Emergence](pandemic-influenza-emergence.md) — influenza surveillance applications

## Confidence Assessment

**High confidence** in application overview based on:
- Comprehensive literature review with 100+ references [1]
- Published in Viruses (MDPI, 2024) — peer-reviewed virology journal [1]
- Authors from established Chinese agricultural/veterinary research institutions [1]

**Moderate confidence** in specific performance claims due to:
- Review format without independent verification of cited studies [1]
- Rapidly evolving field — some cited protocols may be superseded [1]
